McEachin ZT, Chung M, Stratton SA, Han C, Kim WJ, Sheth U, Thomas EV, Issenberg E, Kamra T, Merino P, Levites Y, Raj N, Dammer EB, Duong DM, Ping L, Shantaraman A, Trautwig AN, Gadhavi J, Assefa E, Gearing M, Kelly KM, Roemer SF, DeTure M, Asress S, Kukar T, Fournier C, Dickson DW, Petrucelli L, Golde TE, Oskarsson B, Gendron TF, Seyfried NT, Glass JD. Molecular impact of antisense oligonucleotide therapy in C9orf72-associated ALS. Cell. 2025 Aug 26:S0092-8674(25)00908-0. doi: 10.1016/j.cell.2025.07.045. Epub ahead of print. PMID: 40865525.